Luxembourg Drops Approval for Israel Bonds Issue: What That Means

Luxembourg’s decision not to renew its approval for the bond prospectus of Israel Bonds has sent shockwaves through financial markets. However, what’s more significant is the insight it provides into the complex web of relationships between European countries and the Israeli government.

At its core, the bond prospectus outlines the terms of a loan from investors to the Israeli government. Produced under the supervision of the Luxembourg financial market, Israel Bonds are used as a tool for financing military spending. According to Amnesty International, between October 2023 and January 2025, Israel raised $4.5 billion on international markets through these bonds. This influx of cash has allowed the Israeli government to fund its ongoing war in Gaza, which has had devastating consequences for civilians.

Luxembourg’s decision not to renew its approval is a significant blow to Israel’s ability to borrow in European markets. However, it doesn’t come out of the blue – Ireland previously served as the regulatory home for Israeli bonds before leaving the EU in 2020. Luxembourg took over this role and let the approval expire, raising questions about the motivations behind its decision.

Amnesty International has been vocal in its criticism of EU member states for allowing Israel Bonds to be sold on their markets. In July, they called on all EU countries to stop the sale of these bonds, citing the risk of complicity in Israel’s “ongoing genocide against Palestinians in Gaza.” This statement highlights the human cost of Israel’s military actions and underscores the need for EU member states to take action.

Israel will now need to find another EU country willing to take over as regulatory home. The consequences of this are far-reaching – it could lead to a significant reduction in the amount of money available to fund Israel’s military spending. However, despite this setback, Israel still has access to other markets around the world, notably its major ally, the United States.

The fact that Israel can continue to issue bonds in US markets is telling. Since 1951, the Development Corporation for Israel (DCI) has raised billions of dollars via bonds in the US financial market – about $2.5 billion a year. This highlights the uneven playing field on which European countries and the Israeli government operate.

This story is not just about finance and markets; it’s also about human rights and international law. The fact that EU member states are allowing Israel to continue selling bonds on their markets raises questions about their commitment to upholding these laws. The pressure on countries issuing Israeli bonds has been mounting for months, with Amnesty International at the forefront of this campaign.

In July, they issued a public statement condemning the sale of these bonds, saying it “comes with an enormous ethical and legal cost.” They’re right – international law is clear: all states have an obligation not to aid or assist in genocide. The silence from European capitals on this matter has been deafening, but it’s time for them to break their silence and take action.

The fate of Palestine will continue to hang in the balance until EU member states take a more principled stance on this issue.